May 24, 2016 7:03 am EDT Abeona Therapeutics Announces FDA Allowance of Investigational New Drug (IND) for Phase 1/2 Clinical Study With ABO-101 Gene Therapy for Patients With Sanfilippo Syndrome Type B (MPS IIIB)
May 17, 2016 7:03 am EDT Abeona Therapeutics Doses First Patient in Phase 1/2 Trial With ABO-102 Gene Therapy for Patients With Sanfilippo Syndrome Type A (MPS IIIA)
May 16, 2016 4:37 pm EDT Abeona Therapeutics Announces First Quarter 2016 Summary Financial Results and Recent Operational Highlights
May 3, 2016 8:03 am EDT Abeona Therapeutics Appoints Christine Silverstein as Vice President of Investor Relations
Apr 15, 2016 8:03 am EDT Abeona Therapeutics to Present at Gene, Cell and Molecular Therapies for Inherited Metabolic Diseases Meeting
Mar 21, 2016 9:03 am EDT Abeona Therapeutics to Present at Alliance of Regenerative Medicine's (ARM) 4th Annual Cell & Gene Therapy Investor Day
Mar 8, 2016 9:23 am EST Abeona Therapeutics Announces Fourth Quarter and Full Year 2015 Summary Financial Results and Recent Operational Highlights
Mar 2, 2016 8:19 am EST Abeona Therapeutics Highlights New Preclinical Juvenile Neuronal Ceroid Lipofuscinosis (JNCL) Data at WORLDSymposium(TM) 2016
